ADT-1004

N/A

Report date: 2023/07/19 18:01:15
NME

Base Information

Drug NameADT-1004
Drug Alias NameADT-1004
ClassificationSmall molecules
Mechanisms of ActionGTPase Ras inhibitors
TargetsGTPase Ras
Therapy Area/IndicationsCarcinoma, Pancreatic Ductal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesADT Pharmaceuticals LLC
China Registration ClassN/A

Develop Information

Active CompaniesADT Pharmaceuticals LLC
Inactive CompaniesN/A
Active IndicationsCarcinoma, Pancreatic Ductal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A